public and patient involvement have at their heart the aspiration towards better health outcomes; better for individuals because they are informed, self-managing, making choices and using health services effectively; better for communities because the health care system becomes more responsive, more directed to customer service and quality, and more connected to local need.
The evidence that involvement can do this is building slowly. A recent review in England looked at 12 studies involving patients and concluded: ' Patient involvement increases patient satisfaction. Benefits also include greater confidence, reduction in anxiety, greater understanding of personal needs, improved trust, better relationships with professionals and positive health effects'. 3 The review acknowledges, however, that finding the right process for the task and understanding the situation in which involvement is taking place are essential for a satisfactory outcome.
Ethical issues also need further clarification. Some take the view that all investigation of patient and user perspectives is research and therefore subject to formal research ethics approval. Others say that the ordinary standards of market research are sufficient to cover patient surveys and other customer satisfaction measures. The UK government has prepared guidance on how ethical principles should be applied appropriately and this will be published shortly.
Effective patient or public involvement depends then on clarity of purpose and appropriate methods, commonplace to anyone working in social research. Why the problem then? Perhaps it is revealed when Abelson and colleagues report that adequate recognition of the knowledge that citizens bring to the process is important, combined with the sharing of information between decision-makers and the public. Too often participants feel they are being done to rather than involved, that there is a hidden agenda, that information is being withheld or that decisions have already been made.
Participants in a public involvement exercise in Melbourne, Australia, designed to test different approaches to involvement, overwhelmingly preferred methods which involved substantial information exchange, debate and discussion, and shared decisionmaking, as opposed to those where they were invited to choose or vote merely on the basis of individual or majority opinion. 4 Their clear preference was for citizens' juries or other deliberative approaches.
The research is to be transformative. We need to do the same in other areas of involvement. People taking part in consultations need to be engaged as partners, their expertise acknowledged, objectives need to be explicit, information needs to be shared and communication before, during and after the process needs to be thought through. None of this is difficult, but in the end only if we truly intend to involve people and change what we do as a result will patients and the public have reason to take part.
Harry Cayton Director for Patients and the Public Department of Health Richmond House, 79 Whitehall London SW1A 2NS
The quest for quality in the English NHS: strategic and policy issues
Measuring and improving quality in health care has become a prominent policy imperative across the world. After taking power in 1997, the UK Labour government, set out to place 'quality at the heart of the NHS' by promulgating a ten-year quality initiative in England. 1, 2 Key features included:
. establishing quality of care as a statutory responsibility for chief executives of NHS provider organisations via the mechanism of clinical governance; . the development and dissemination of evidence-based guidelines and national standards (via National Service Frameworks [NSFs] and the National Institute for Clinical Excellence); . introduction of new regulatory mechanisms in the form of an inspectorate (now the Healthcare Commission); . the identification of primary care organisations as commissioning (purchasing) agents with responsibilities to improve quality of care; . specification of targets for quality improvement in many areas of access and effectiveness; . introduction of new financial and non-financial incentives to improve quality in organisational and individual performance.
Importantly, the focus on quality was accompanied by an acknowledgement that the NHS was underfunded in comparison with other western European countries and, in 2002, it was announced that annual expenditures would increase by 7.4% in real terms each fiscal year from 2003-04 to 2007-08. 3 In November 2003, we published a report The Quest for Quality in the NHS which evaluated the ten-year quality initiative at its midpoint. 4 We characterised the initiative as the 'most ambitious, comprehensive, systemic and intentionally funded effort to create predictable and sustainable capacity for improving the quality of a nation's health care system'. Two questions were fundamental to our evaluation: whether the policy initiatives for building predictable systemic capacity for quality improvement were coherent and cogent and; what evidence there was of impact to date.
The quality initiative in England has given rise to a raft of new organisations and programmes concerned with a diverse range of responsibilities and functions. It has resulted in a coherent and comprehensive set of policies which should enable the system to capitalise on increased investment. There are however a number of vulnerabilities, which could, if unchecked, become fatal flaws: IT and informatics weaknesses; lack of professional engagement; diffuse conceptualisation of the place of market dynamics and patient choice; and data and analytic skills poorly distributed throughout the country.
In the Quest for Quality, we applied internationally accepted domains of quality to evaluate impact: access to care; effectiveness of care; system capacity; patient centredness; and disparities. Much of the government's reform effort has focused on waiting times as a proxy for access. Significant progress has been achieved. For example, in 1999-2000 approximately 50 000 patients waited more than 12 months for admission to hospital; by January 2004, this figure had fallen to 36. Waiting times can harm effectiveness. For example, breast cancer survival rates in 1985-89 compared unfavourably with other similar countries, 5 explained in part by the lag between a suspected diagnosis of cancer and an appointment with a specialist. Latest figures show that 98% of patients with suspected breast cancer are seen by a specialist within 14 days. Despite these successes, access problems remain. For example, the average wait for a routine MRI scan is around 132 days. 6
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